---
title: "$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293386862.md"
description: "Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years with an annualized return of 13.64%, beating the market by 1.3%. A $100 investment made 15 years ago would now be worth $669.54, based on a current stock price of $366.24. The company currently holds a market capitalization of $197.77 billion."
datetime: "2026-07-21T21:00:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293386862.md)
  - [en](https://longbridge.com/en/news/293386862.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293386862.md)
generator: "portal-rs"
---

# $100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

Amgen (NASDAQ:AMGN) has outperformed the market over the past 15 years by 1.3% on an annualized basis producing an average annual return of 13.64%. Currently, Amgen has a market capitalization of $197.77 billion.

**Buying $100 In AMGN:** If an investor had bought $100 of AMGN stock 15 years ago, it would be worth **$669.54** today based on a price of $366.24 for AMGN at the time of writing.

### Amgen’s Performance Over Last 15 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/07/21/766dc198a2921d42f1206f3b697b46f6.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [Nilsine Partners LLC Makes New Investment in Amgen Inc. $AMGN](https://longbridge.com/en/news/298130227.md)
- [Amgen (NASDAQ:AMGN) Shares Sold Off Sen. Sheldon Whitehouse](https://longbridge.com/en/news/298095084.md)
- [What's Going On With Amgen Stock Tuesday?](https://longbridge.com/en/news/298350093.md)
- [Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen](https://longbridge.com/en/news/298345109.md)
- [NWF Advisory Services Inc. Sells 4,116 Shares of Amgen Inc. $AMGN](https://longbridge.com/en/news/298021972.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**